For: | Fuster D, Mayoral M, Rubello D, Pineda E, Fernández-Esparrach G, Pagès M, Colletti PM, Pons F. Is there a role for PET/CT with esophagogastric junction adenocarcinoma? Clin Nucl Med. 2015;40:e201-e207. [PMID: 25546207 DOI: 10.1097/RLU.0000000000000661] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis] |
---|
Number | Citing Articles |
1 | Wang RF, Chen XQ. Application of PET/CT in gastrointestinal cancers. Shijie Huaren Xiaohua Zazhi 2016; 24(35): 4652-4659 [DOI: 10.11569/wcjd.v24.i35.4652] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis] |
2 | Park JK, Kim JJ, Moon SW. A study about different findings of PET-CT between neoadjuvant and non-neoadjuvant therapy: SUVmax is not a reliable predictor of lymphatic involvement after neoadjuvant therapy for esophageal cancer. J Thorac Dis. 2016;8:784-794. [PMID: 27162651 DOI: 10.21037/jtd.2016.03.20] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis] |
3 | Scharitzer M, Pokieser P. What is the role of radiological testing of lower esophageal sphincter function? Ann N Y Acad Sci 2016;1380:67-77. [PMID: 27496165 DOI: 10.1111/nyas.13181] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis] |